ORTHO CORONA – IMPORTANT INFORMATION

Laboratories across the world of ortho corona virus have been tasked with the incredible responsibility of delivering consistently fast, accurate, reliable and actionable test results as healthcare professionals, researchers, and government officials race to find solutions to stop this devastating pandemic.

Ortho Clinical Diagnostics always find a solution to supply sustainable solutions, that facilitate reliable, accurate, actionable results – even in times of crisis because they believe every test may be a LifeTM. Moments like this reminds us why we work hard to help ensure laboratories around the world have the results they need to protect patient lives. We understand that behind every test our instruments process, there is a patient life. During this pandemic time, it could mean millions of lives.

ORTHO CORONA DIAGNOSTICS:

Ortho Clinical Diagnostics has launched a replacement COVID-19 antibody test VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test, following the US Food and Drug Administration (FDA) Emergency Use Authorization.

The company said that new Anti-SARS-CoV-2 IgG Test is its second FDA authorized COVID-19 total antibody test, and both of its COVID-19 tests have 100% specificity.

Ortho Clinical Diagnostics chief innovation officer Chockalingam Palaniappan said: “Both tests run on the widely used Ortho VITROS platform and the results will paint a vivid picture of a patient’s immune response status.

ANTIBODY SEROLOFY ORTHO CORONA TEST:

Antibody serology (blood based) ortho corona tests can identify individuals who have developed an immune reaction to the SARS-CoV-2 virus. These tests can aid in diagnosing symptomatic or asymptomatic individuals of acute infection together with molecular ortho corona tests or clinical information. They also can identify individuals who have previously been infected with the SARS-CoV-2 virus and recovered.

Antibody serology (blood based) tests can identify individuals who have developed an immune reaction to the SARS-CoV-2 virus. These tests can aid in diagnosing symptomatic or asymptomatic individuals of acute infection together with molecular tests or clinical information. They also can identify individuals who have previously been infected with the SARS-CoV-2 virus and recovered.

COVID-19 ORTHO CORONA:

To develop the COVID-19 complete antibody test, Ortho built on our history and knowledge of developing world-class infectious disease tests to ensure the excellent clinical sensitivity and specificity performance of the COVID-19 tests, which are critical to make sure confidence within the results these tests deliver. Watch the video at right to hear more.

Now more than ever, we see the critical role the lab and their staff play in helping clinicians quickly and accurately diagnose and triage patients within the overburdened hospitals during this pandemic.

AFFLICTED PATIENTS:

For patients afflicted with the SARS-CoV-2 virus, information provided by the lab can help assess the severity of the infection and monitor therapeutic interventions. Anti-SARS-CoV-2 antibody tests can help evaluate the body’s immune response to the disease.

Now more than ever, we see the critical role the lab and their staff play in helping clinicians quickly and accurately diagnose and triage patients within the overburdened hospitals during this pandemic.

For patients afflicted with the SARS-CoV-2 virus, information provided by the lab can help assess the severity of the infection and monitor therapeutic interventions. Anti-SARS-CoV-2 antibody tests can help evaluate the body’s immune response to the disease.

INFORMATION ON ORTHO CORONA:

 Clinicians will now have invaluable information which will allow them to form decisions about the propriety of a patient returning to figure. No doubt about that it is very crucialinformation for first responders, health care professionals and other essential personnel working with affected populations.

Ortho’s new COVID-19 IgG antibody test are often run on its automated analyzers. Ortho said that its total antibody test will detect all COVID-19 related antibodies, including IgM, which appears within the early, acute stage of infection. The new test also helps determine the onset of a patient’s immune response by monitoring all antibodies generated through disease progression.

In addition, the test will only detect the IgG antibody which is found within the blood of patients within the later phase of the infection and remains elevated even after recovery. Both the company’s COVID-29 tests are said to help health care professionals to know whether a patient has been exposed to and has developed antibodies to the COVID-19 virus.

The test has been designed to run on the company’s VITROS XT 7600 Integrated System, VITROS 3600 Immunodiagnostic System, VITROS 5600 Integrated System and will be available soon on VITROS ECi/ECiQ Immunodiagnostic Systems. VITROS Systems are already installed in more than 1,000 hospitals and reference labs in the US, and are self-contained. The systems do not need an external water source to run, offering labs placement flexibility.

Ortho Clinical Diagnostics chief executive officer Chris Smith said: “Ortho is proud that both of our COVID-19 total and IgG tests are achieving 100% specificity. During this health crisis, good is just not ok. This high level of specificity may be a testament to Ortho’s conviction that each test may be a life.”